Cardiac assist devices are medical systems that support or temporarily replace the pumping function of a weakened heart. They include total artificial hearts, intra-aortic balloon pumps and ventricular assist devices, and they are used for patients with advanced heart failure and other severe cardiac conditions. As cardiovascular disease becomes more prevalent worldwide, demand for reliable circulatory support continues to rise. This trend is strengthening the outlook of the cardiac assist devices market over the coming years.
The global Cardiac Assist Devices Market size is witnessing strong growth as healthcare providers continue to prioritize advanced heart failure management and device innovation. According to The Insight Partners, the market is projected to grow from US$ 2.17 billion in 2024 to US$ 3.84 billion by 2031, registering a CAGR of 8.5% during the forecast period from 2025 to 2031. Rising cardiovascular disease burden, technological advancements and patient-centric care approaches are supporting the expansion of this market globally.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPMD00002382
Market Growth Supported by Expanding Cardiac Care Demand
The cardiac assist devices market is benefiting from the increasing need for devices that sustain heart function at critical levels. Growing diagnosis of cardiovascular conditions, advances in device design and stronger clinical adoption are contributing to wider use of these technologies.
Healthcare providers are increasingly focused on solutions that improve patient outcomes, comfort and quality of life. This shift is creating opportunities for medical device manufacturers, hospitals and research organizations involved in heart failure treatment. As awareness expands and access to advanced cardiac care improves, the market is expected to maintain a positive growth trajectory through 2031. The projected rise from US$ 2.17 billion in 2024 to US$ 3.84 billion by 2031 highlights continued investment and growing clinical demand. With a CAGR of 8.5%, the sector is expected to remain a high-growth segment within the cardiovascular devices industry.
Buy Premium Report: https://www.theinsightpartners.com/buy/TIPMD00002382
Industry Trends Driving the Market
Several important trends are shaping the future of the cardiac assist devices market globally.
Patient-centric approaches: Devices designed around individual patient needs, and greater patient involvement in treatment decisions, are improving adherence, care experience and outcomes.
Rising prevalence of cardiovascular diseases: A growing number of diagnosed patients is increasing demand for robust devices that support heart function and encouraging investment in innovation.
Technological advancements: Miniaturized designs, improved materials and remote monitoring are making implantation easier, reducing complications and enabling real-time patient management.
Acquisitions and product launches: Established companies are using acquisitions to access new technologies and accelerate the introduction of new devices.
AI and IoT integration: Artificial intelligence and connected technologies can help predict complications, personalize treatment and support timely alerts to healthcare providers.
Increasing product approvals: A rising number of regulatory approvals is encouraging R&D investment and widening patient access to advanced devices.
These trends are collectively strengthening the market outlook and helping drive industry expansion during the forecast period.
Market Opportunities
- Minimally invasive implantation techniques: These can mean shorter hospital stays and faster recovery, and may extend treatment to patients who are too frail for open-heart surgery.
- Growing research funding for heart failure: Increasing investment, funds and grants are supporting innovation and collaboration between industry and research institutions.
- Telehealth integration: Real-time monitoring of device performance and patient health supports proactive care management and better treatment adherence.
Market Segmentation
The report segments the cardiac assist devices market as follows:
- By Product: Total Artificial Heart, Intra-Aortic Balloon Pumps (IABPs), Ventricular Assist Devices
- By Modality: Transcutaneous, Implantable
- By End User: Hospital Pharmacies, Ambulatory Surgical Centre, Others
- By Geography: North America, Europe, Asia-Pacific, South and Central America, and Middle East and Africa
Competitive Landscape: Top Key Players
The cardiac assist devices market includes several major companies focused on device innovation and market expansion. Key players highlighted in the report include:
- Thoratec Corporation
- MAQUET GmbH & Co.
- Teleflex Incorporated
- HeartWare International
- Berlin Heart
- ABIOMED
- SynCardia Systems
- Abbott
- Medtronic
- Terumo Corporation
These companies continue to focus on strengthening their product portfolios and expanding their presence in the global cardiac care sector.
Regional Outlook
The cardiac assist devices market continues to expand globally as healthcare systems strengthen their focus on heart failure treatment and advanced cardiac care. According to the report, Asia Pacific held the largest share of the market. The United States represents a key market, supported by patient-centric approaches, the rising prevalence of cardiovascular diseases and technological advancements. Growing healthcare investment across North America, Europe, Asia-Pacific, South and Central America, and the Middle East and Africa is expected to contribute to sustained growth throughout the forecast timeline.
As device technologies continue to evolve, manufacturers and healthcare providers are expected to focus on improving access, safety and long-term patient outcomes. This will remain an important factor supporting future market development.
Future Outlook Through 2031
The market outlook remains positive as demand for effective circulatory support continues to increase. With stronger awareness of cardiovascular disease, ongoing technological innovation and rising investment in heart failure research, the sector is positioned for robust expansion. By reaching US$ 3.84 billion by 2031 from US$ 2.17 billion in 2024, the cardiac assist devices market demonstrates strong long-term opportunity. The expected CAGR of 8.5% reflects growing demand and sustained interest from healthcare providers and medical device manufacturers worldwide.
Related Reports –
Cardiopulmonary Oxygenator Market Size, Growth & Future Trends by 2034
Artificial Heart Market Drivers, Opportunities, Trends, and Forecasts by 2031
About Us
The Insight Partners, we provide comprehensive analysis and insights into market trends that empower businesses to make informed decisions. Our reports are designed to equip stakeholders with the necessary information to navigate the complexities of various industries, including healthcare, technology, and finance. We are dedicated to delivering high-quality research that enables our clients to achieve their strategic objectives.
Contact Us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
Press Release Source: Read the original article
